3-(2,6-dioxopiperidin-3-yl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
Structure Info
- Chemspace ID
- CSSB06744473684 (In-Stock Building Blocks)
- CAS
- 3017242-74-6
- MFCD
- MFCD35080255
- IUPAC Name
- 3-(2,6-dioxopiperidin-3-yl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
- Mol formula
- C23H23BN2O6
- Mol weight
- 434 Da
- Catalog Number(s)
- BBLS06744473684, EN300-39926894, Z7783943767, ZX-NM284599, bbls06744473684
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.49
- Heavy atoms count
- 32
- Rotatable bond count
- 2
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.391
- Polar surface area (Å)
- 102
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 1
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione (C23H23BN2O6) - CSSB06744473684](/st/structure/200/f68e80d518c3b7de62b195be8df56068/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c1cc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc%2528c1%2529c23.png "C23H23BN2O6")
- Zoom the structure
- CSSB06744473684
Items Overall 23 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 229.12 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 310.23 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 460.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 541.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 663.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 326.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 486.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 693.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 1,092.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 1,400.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 2,745.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 4,060.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 326.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 486.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 693.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 1,092.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 1,400.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 2,745.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 229.12 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 310.23 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 460.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 541.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 663.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of [3-(2,6-dioxopiperidin-3-yl)-2,4-dioxo-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-7-yl]boronic acid - CSSB14948340480](/st/structure/200/1dc37d1287ea0095b22f4189868c20f7/OB%2528O%2529C1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744500023](/st/structure/200/d71651813c7115e719539f57ee07767c/O%253DC1CCC%2528N2C%2528%253DO%2529c3cccc4cccc%2528C2%253DO%2529c34%2529C%2528%253DO%2529N1.png)
![Chemical structure of 2-(2,6-dioxopiperidin-3-yl)-4-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethynyl}-2,3-dihydro-1H-isoindole-1,3-dione - CSSB21415981077](/st/structure/200/4fe5b974104fdf457d1961a2eda44056/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2523CC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of 7-amino-3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744473716](/st/structure/200/b4ed55e93754429139dda514ad3c1cda/Nc1cc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc%2528c1%2529c23.png)
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-7-hydroxy-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB03437847384](/st/structure/200/e0188638ef7df14a125803331426d2bd/OC1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
![Chemical structure of 7-amino-3-[(3S)-2,6-dioxopiperidin-3-yl]-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB21511091586](/st/structure/200/2d6a8422c85c5ef022c5424f017bc34b/NC1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528%255BC%2540H%255D1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
